| Stage | NOG | % of rev | WERN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $745M | 100.00% | $934M | 100.00% | WERN ×1.25 |
| Gross profit | $618M | 82.95% | $503M | 53.87% | NOG +29.1pp |
| Operating income | $353M | 47.31% | $17M | 1.81% | NOG +45.5pp |
| Pre-tax income | $311M | 41.68% | $7M | 0.79% | NOG +40.9pp |
| Net income | $237M | 31.75% | $5M | 0.57% | NOG +31.2pp |
| Stage | NOG | WERN | Gap · A − B |
|---|---|---|---|
| Revenue | $745M100.00% | $934M100.00% | WERN ×1.25 |
| Gross profit | 82.95%$618M | 53.87%$503M | NOG +29.1pp |
| Operating income | 47.31%$353M | 1.81%$17M | NOG +45.5pp |
| Pre-tax income | 41.68%$311M | 0.79%$7M | NOG +40.9pp |
| Net income |
| 31.75%$237M |
| 0.57%$5M |
| NOG +31.2pp |
No shared counterparties.